HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abraham Avigdor Selected Research

Therapeutics

1/2022Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies.
1/2022Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
2/2021A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia.
1/2021Multiple Myeloma Presenting in Patients Younger than 50 Years of Age: A Single Institution Experience.
1/2021Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience.
1/2021Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma.
1/2021Characteristics and risk factors of infections following CD28-based CD19 CAR-T cells.
11/2020Progression of disease within 24 months of initial therapy (POD24) detected incidentally in imaging does not necessarily indicate worse outcome.
6/2020Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia.
1/2020Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abraham Avigdor Research Topics

Disease

11Lymphoma (Lymphomas)
04/2022 - 04/2002
11Neoplasms (Cancer)
01/2022 - 10/2003
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2022 - 01/2003
7Multiple Myeloma
12/2020 - 09/2014
6Leukemia
01/2022 - 01/2003
5B-Cell Lymphoma (Lymphoma, B Cell)
10/2022 - 01/2008
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2022 - 01/2008
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2022 - 10/2003
5Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020 - 08/2003
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 02/2016
4Neutropenia
10/2019 - 08/2003
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 08/2003
3Hodgkin Disease (Hodgkin's Disease)
12/2021 - 04/2008
2Disease Progression
12/2020 - 02/2016
2Thrombocytopenia (Thrombopenia)
02/2016 - 03/2015
1Cardiotoxicity
02/2021
1Bacterial Infections (Bacterial Infection)
01/2021
1Proteinuria
01/2021
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2020
1T-Cell Lymphoma (Lymphoma, T Cell)
12/2019
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2019
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
12/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019
1Chromosome Aberrations (Chromosome Abnormalities)
01/2019
1Pathologic Complete Response
10/2018
1Pediatric Obesity
04/2016
1Inflammation (Inflammations)
04/2016
1Infections
01/2016
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2016
1Hyperbilirubinemia
03/2015
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2014

Drug/Important Bio-Agent (IBA)

8Chimeric Antigen ReceptorsIBA
04/2022 - 12/2018
7Rituximab (Mabthera)FDA Link
12/2020 - 08/2003
4Dexamethasone (Maxidex)FDA LinkGeneric
12/2020 - 09/2014
4Bortezomib (Velcade)FDA Link
12/2020 - 09/2014
4Bendamustine HydrochlorideFDA Link
12/2020 - 01/2016
3AnthracyclinesIBA
02/2021 - 01/2008
3ibrutinibIBA
12/2020 - 02/2016
3Deoxyglucose (2 Deoxy D glucose)IBA
08/2014 - 04/2008
3Proteins (Proteins, Gene)FDA Link
01/2008 - 10/2003
3Dual Specificity Phosphatase 1IBA
10/2003 - 01/2003
2Messenger RNA (mRNA)IBA
01/2022 - 10/2003
2STK405759IBA
07/2018 - 01/2016
2Thalidomide (Thalomid)FDA Link
02/2015 - 09/2014
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2015 - 09/2014
2FluorineIBA
11/2014 - 08/2014
2ibritumomab tiuxetan (Zevalin)FDA Link
10/2012 - 04/2007
1Immunoglobulins (Immunoglobulin)IBA
10/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2022
1Pyridinolcarbamate (P23)IBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1Brentuximab VedotinIBA
12/2021
1anthraceneIBA
02/2021
1bisantreneIBA
02/2021
1polatuzumab vedotinIBA
01/2021
1selinexorIBA
12/2020
1Cytarabine (Cytosar-U)FDA LinkGeneric
06/2020
1Mitoxantrone (Novantrone)FDA LinkGeneric
06/2020
1romidepsin (FK228)FDA Link
12/2019
1Histone Deacetylase InhibitorsIBA
12/2019
1Histone Deacetylases (Histone Deacetylase)IBA
12/2019
1GemcitabineFDA Link
01/2019
1Complement System Proteins (Complement)IBA
01/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018
1Dacarbazine (DIC)FDA LinkGeneric
10/2018
1Vinblastine (Vinblastine Sulfate)FDA Link
10/2018
1Vincristine (Oncovin)FDA LinkGeneric
10/2018
1Angiogenesis InhibitorsIBA
07/2018
1Cytotoxins (Cytolysins)IBA
07/2018
1Immunomodulating AgentsIBA
01/2017
1Monoclonal AntibodiesIBA
01/2017
1Programmed Cell Death 1 ReceptorIBA
01/2017
1ThrombinFDA Link
01/2017
1Immune Checkpoint InhibitorsIBA
01/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2016
1Agammaglobulinaemia Tyrosine KinaseIBA
02/2016
1EnzymesIBA
03/2015
1Biological ProductsIBA
01/2015
1AntibodiesIBA
01/2015
1Pharmaceutical PreparationsIBA
09/2014
1BKT140IBA
07/2013
1Yttrium-90IBA
10/2012
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
03/2009
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2008
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2008
1LigandsIBA
01/2008
1CXCR4 Receptors (CXCR4 Receptor)IBA
11/2006
1Peptide Hydrolases (Proteases)FDA Link
09/2005
1Pancreatic Elastase (Elastase)IBA
09/2005

Therapy/Procedure

24Therapeutics
01/2022 - 04/2002
14Drug Therapy (Chemotherapy)
03/2022 - 08/2003
6Stem Cell Transplantation
12/2021 - 08/2003
4Immunotherapy
01/2022 - 01/2015
2Induction Chemotherapy
02/2022 - 01/2022
1Transplantation
01/2022
1Hematopoietic Stem Cell Transplantation
01/2020
1Salvage Therapy
01/2019
1Radiotherapy
10/2018